DETROIT -- Indians reliever Joe Colon received a suspension from the league office for testing positive for a performance-enhancing substance.

Colon's ban will cover the remainder of the 2017 season. The right-hander was pitching at Triple-A Columbus.

Colon, 27, tested positive for a selective androgen receptor modulator (modulator LGD-4022, to be specific). He was also suspended in January 2016 for his second positive test for a drug of abuse. That ban lasted 50 games.

Following his return, he made 11 appearances for the Indians last season. At Columbus this year, he posted a 4.13 ERA across 28 outings. He owns a career 3.44 ERA during his minor-league career. The Indians selected him in the 12th round of the 2009 amateur draft.

In 20 games at Triple-A last season, Colon logged a 0.82 ERA, with only eight hits allowed in 22 innings.

Steve Delabar, who was assigned to Triple-A Columbus at the end of spring training, received an 80-game suspension in April for a positive PED test.

Last season, outfielders Marlon Byrd and Abraham Almonte received PED-related suspensions.